Supercharge Your Innovation With Domain-Expert AI Agents!

Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome

A technology for chronic prostatitis and pelvic pain, applied in the direction of drug combinations, organic active ingredients, medical preparations containing active ingredients, etc., can solve problems such as the relationship between chronic prostatitis that has not been reported

Pending Publication Date: 2022-08-05
NIPPON SHINYAKU CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, so far, the relationship between chronic prostatitis and the mPGES-1 pathway has not been reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome
  • Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome
  • Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0438] Hereinafter, the present invention will be described in more detail with reference to Reference Examples, Examples, Test Examples, and Formulation Examples, but the present invention is not limited thereto.

[0439] The test compounds used in Test Examples 1 and 2 are as follows.

[0440] The compounds used in Test Examples 1 and 2 were prepared and used according to the description in Examples 1 to 249 of WO2013 / 024898. The activity data of the compounds used in Test Examples 1 and 2 are shown in Tables 1 to 17 of WO2013 / 024898.

preparation example 1

[0523] Tablet (Oral tablet)

[0524] In prescription 1 tablet 80mg

[0525]

[0526] The mixed powder of this ratio is compressed and molded by a usual method to prepare an oral tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a prophylactic and / or therapeutic agent for chronic prostatitis / chronic pelvic pain syndrome, which contains an mPGES-1 inhibitor as an active ingredient.

Description

technical field [0001] The present invention relates to a preventive and / or therapeutic agent for chronic prostatitis / chronic pelvic pain syndrome containing an mPGES-1 inhibitor as an active ingredient. Background technique [0002] Prostatitis is classified into 4 categories (acute bacterial prostatitis, chronic bacterial prostatitis, chronic prostatitis / chronic pelvic pain syndrome, asymptomatic inflammatory prostatitis) by the US NIH (Non-Patent Document 1). Category I is acute bacterial prostatitis with systemic symptoms such as urination symptoms, pain, and fever due to bacterial infection. Category II is chronic bacterial prostatitis, which is a chronic form of category I, and is confirmed to have symptoms of recurrent bacterial infection. Category III is chronic prostatitis / chronic pelvic pain syndrome, and is classified as a disease with urination symptoms such as pain / discomfort in the pelvic area such as the perineum, testicles, penis, and lower abdomen, residual...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/343A61K31/416A61K31/4184A61K31/423A61P13/08
CPCA61K31/343A61P13/08A61K31/423A61K31/416A61K31/4184A61K45/06A61K31/454A61K31/506A61K45/00A61P29/00
Inventor 冈本贤栗田麻希山口浩史
Owner NIPPON SHINYAKU CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More